BioSpace News Archive

SAN DIEGO , Feb. 24, 2020 /PRNewswire/ -- Neurelis, Inc., today announced that the company will be participating in the SVB Leerink 9 th Annual Global Healthcare Conference at Lotte New York Palace, New York City. Neurelis President and CEO Craig Chambliss will present at 2:15 pm EST on Tuesday , February 25. About Neurelis

Challenge accepted by Pro Football Hall of Fame wide receiver Jerry Rice, fans encouraged to share their best ’40-yard-dash’

Feb. 24, 2020 14:00 UTC Applied DNA Announces Receipt of International Patents on its Beacon ® Secure Optical Molecular Marker Technologies New Patents in Key International Markets Allow 1 st -Level Verification in Seconds STONY BROOK, N.Y.--( BUSINESS WIRE )-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that brings integrity to global supply chains, and innovation to diagnosti

Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Patrick Nelli, Chief Financial Officer, and Adam Brown, Senior Vice President, Investor Relations, will participate in the following upcoming investor conference.

Ljubljana, Slovenia, Feb. 24, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “ OTC:(RAFA)” is pleased to inform its shareholders that the previously-announced specialized research project between Rafarma and Khon Kaen University officially commenced on February 19, 2020. In a meeting at the University, Rafarma discussed entering the Thai market and implemented certain changes in the research planned for the next two years. Rafarma and MTP MATERIAL CO. LTD. Have formulated a plan to be

CAMBRIDGE, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president and CEO, will present the latest company overview at the 40 th Annual Cowen Healthcare Conference in Boston on Monday, March 2, 2020 at 11:20am Eastern Time. A live webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation webs

HASBROUCK HEIGHTS, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce that a new peer review report was published today in the World Journal of Urology, documenting the successful long-term clinical trial results after Fexapotide Triflutate treatment for early stage prostate cancer. This report represents the first publication in the medical literature of multi-year long-term data from a well-powered prospective randomized multi-cen

SkinCeuticals, the brand known for advanced, professional-grade skincare backed by science, announces the opening of SkinCeuticals SkinLab™ in partnership with NicholsMD.

The Medical Science Liaison Society (MSL Society), the only 501c3 non-profit organization exclusively dedicated to the global medical science liaison (MSL) profession, announced today that it has launched the first-ever professional board certification for Medical Science Liaisons (MSL) and MSL leaders.

STOCKHOLM , Feb. 24, 2020 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announces today that the company has signed a licensing agreement for Medivir’s Xerclear® for labial herpes with the Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd (SYB). The agreement gives SYB the right to register, manufacture and market the product in China . After market registrati